MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Personal history of COVID-19 (Z86.16)

HealthDay 19 January at 04.58 PM

COVID-19 Vaccine Uptake Lagging in Patients With Sickle Cell Disease

COVID-19 immunization completion is nearly half for people with versus without sickle cell disease (SCD), according to a research letter published online Jan. 8 in JAMA Network Open.Hannah K. Peng, from the University of Michigan in Ann Arbor, and colleagues assessed COVID-19 immunization coverage among 3,424 Michigan residents wit

HealthDay 13 January at 12.09 AM

Decrease in Head and Neck Cancer Incidence Seen During Pandemic

During the first year of the COVID-19 pandemic, the incidence of head and neck cancer (HNC) decreased, according to a study published online Jan. 11 in JAMA Otolaryngology-Head & Neck Surgery.Jason Semprini, Ph.D., from the University of Iowa College of Public Health in Iowa City, and colleagues examined the change in localized vers

HealthDay 12 January at 04.41 PM

Vegetarian Diet Tied to Lower COVID-19 Incidence

A vegetarian diet is associated with a lower incidence of COVID-19 infection, according to a study published online Jan. 9 in BMJ Nutrition, Prevention & Health.Júlio César Acosta-Navarro, M.D., Ph.D., from Universidade de Sao Paulo in Brazil, and colleagues examined whether there is an association between a plant-based or vege

HealthDay 08 January at 11.40 PM

BNT162b2 Effective for Children, Teens During Delta, Omicron Waves

In children and adolescents, BNT162b2 was effective for COVID-19-related outcomes during the delta and omicron periods, according to a study published online Jan. 9 in the Annals of Internal Medicine.Qiong Wu, Ph.D., from the University of Pennsylvania Perelman School of Medicine in Philadelphia, and colleagues examined the effectiveness

HealthDay 08 January at 11.40 PM

BNT162b2 Effective for Children, Teens During Delta, Omicron Waves

In children and adolescents, BNT162b2 was effective for COVID-19-related outcomes during the delta and omicron periods, according to a study published online Jan. 9 in the Annals of Internal Medicine.Qiong Wu, Ph.D., from the University of Pennsylvania Perelman School of Medicine in Philadelphia, and colleagues examined the effectiveness

Evalytics 08 January at 09.25 PM

JN.1 variant makes up a majority of COVID cases in the US. Here's what to know

The article discusses the emergence of the JN.1 variant, which has become the dominant strain in the United States, raising concerns about its potential impact on COVID-19 cases.

Evalytics 05 January at 08.32 PM

COVID variant JN.1 listed as ‘variant of interest’ by World Health Organization

The World Health Organization has labeled the COVID variant JN.1 as a "variant of interest." While it's not more severe, it accounts for 21% of new cases in the U.S., mainly in the Northeast. Current tests and treatments are still effective, but caution is advised during the holiday season to prevent transmission.

HealthDay 28 December at 11.36 PM

Nearly Half of U.S. COVID-19 Cases Now Caused by JN.1 Variant

The JN.1 variant, a descendant of the variant BA.2.86, now accounts for 44 percent of COVID-19 cases, up from roughly 7 percent in late November, the latest data from the U.S. Centers for Disease Control and Prevention show.The speed at which the JN.1 variant has sprea

HealthDay 28 November at 10.49 PM

Prevalence of COVID-19 Variant BA.2.86 Rising in the United States

The U.S. Centers for Disease Control and Prevention is warning of a highly mutated COVID-19 variant, the prevalence of which has tripled in the past two weeks. Now, nearly one in 10 new COVID-19 cases are fueled by the BA.2.86 variant.The variant is spreading the fastest in the Northeast: Just over 13 percent of cases in the New York and New Je

HealthDay 27 November at 04.31 PM

COVID-19 Vaccination Before Infection Cuts Risk for Long COVID

COVID-19 vaccination before infection is associated with a reduced risk for post-COVID-19-condition (PCC), according to a study published online Nov. 22 in The BMJ.Lisa Lundberg-Morris, from the University of Gothenburg in Sweden, and colleagues conducted a population-based cohort study to examine the effectiveness of primary COVID-19 v

HealthDay 31 October at 03.44 PM

Paxlovid Not Helpful for Reducing Most Post-COVID-19 Conditions

Outpatient treatment of COVID-19 with nirmatrelvir-ritonavir (Paxlovid) reduces the risk for combined thromboembolic events, but does not affect the risk for other post-COVID-19 conditions (PCCs), according to a study published online Oct. 31 in the Annals of Internal Medicine.George N. Ioannou, B.M.B.Ch., from the University of Washin

HealthDay 30 October at 09.26 PM

Transient Decrease in Pediatric Bronchiolitis Hospitalizations Seen During Pandemic

During the COVID-19 pandemic era, pediatric bronchiolitis hospitalizations decreased transiently, then increased, according to a study published online Oct. 26 in JAMA Network Open.Kailey A. Remien, D.O., from Akron Children's Hospital in Ohio, and colleagues conducted a retrospective cross-sectional study using data from 41 U.S. childr

HealthDay 30 October at 09.22 PM

Infectious Diseases Society of America, Oct. 11-15

The annual meeting of the Infectious Diseases Society of America was held this year from Oct. 11 to 15 in Boston and attracted participants from around the world, including scientists, physicians, and other health care professionals. The conference featured education courses and comprehensive educational programs that focused on the latest advances in the d